Your browser doesn't support javascript.
Sleep apnoea is a risk factor for severe COVID-19.
Strausz, Satu; Kiiskinen, Tuomo; Broberg, Martin; Ruotsalainen, Sanni; Koskela, Jukka; Bachour, Adel; Palotie, Aarno; Palotie, Tuula; Ripatti, Samuli; Ollila, Hanna M.
  • Strausz S; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
  • Kiiskinen T; Orthodontics, Department of Oral and Maxillofacial Diseases, Clinicum, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Broberg M; Department of Oral and Maxillofacial Diseases, Helsinki University Hospital (HUH), Helsinki, Finland.
  • Ruotsalainen S; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
  • Koskela J; Finnish Institute for Health and Welfare, Helsinki, Finland.
  • Bachour A; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
  • Palotie A; Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
  • Palotie T; Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  • Ripatti S; Sleep Unit, Heart and Lung Center, Helsinki University Hospital (HUH), Helsinki, Finland.
BMJ Open Respir Res ; 8(1)2021 01.
Article in English | MEDLINE | ID: covidwho-1066894
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT

BACKGROUND:

Obstructive sleep apnoea (OSA) is associated with higher body mass index (BMI), diabetes, older age and male gender, which are all risk factors for severe COVID-19.We aimed to study if OSA is an independent risk factor for COVID-19 infection or for severe COVID-19.

METHODS:

OSA diagnosis and COVID-19 infection were extracted from the hospital discharge, causes of death and infectious diseases registries in individuals who participated in the FinnGen study (n=260 405). Severe COVID-19 was defined as COVID-19 requiring hospitalisation. Multivariate logistic regression model was used to examine association. Comorbidities for either COVID-19 or OSA were selected as covariates. We performed a meta-analysis with previous studies.

RESULTS:

We identified 445 individuals with COVID-19, and 38 (8.5%) of them with OSA of whom 19 out of 91 (20.9%) were hospitalised. OSA associated with COVID-19 hospitalisation independent from age, sex, BMI and comorbidities (p-unadjusted=5.13×10-5, OR-adjusted=2.93 (95% CI 1.02 to 8.39), p-adjusted=0.045). OSA was not associated with the risk of contracting COVID-19 (p=0.25). A meta-analysis of OSA and severe COVID-19 showed association across 15 835 COVID-19 positive controls, and n=1294 patients with OSA with severe COVID-19 (OR=2.37 (95% 1.14 to 4.95), p=0.021).

CONCLUSION:

Risk for contracting COVID-19 was the same for patients with OSA and those without OSA. In contrast, among COVID-19 positive patients, OSA was associated with higher risk for hospitalisation. Our findings are in line with earlier works and suggest OSA as an independent risk factor for severe COVID-19.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Sleep Apnea, Obstructive / COVID-19 Type of study: Observational study / Prognostic study / Reviews Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Year: 2021 Document Type: Article Affiliation country: Bmjresp-2020-000845

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Sleep Apnea, Obstructive / COVID-19 Type of study: Observational study / Prognostic study / Reviews Limits: Aged / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: English Year: 2021 Document Type: Article Affiliation country: Bmjresp-2020-000845